Condition
Trigeminal Neuropathic Pain
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
8 treatments under study, led by Sham Tdcs Prior To Real Tdcs
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Phase 1 (1)
Trial Status
Completed1
Terminated1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03309813Not ApplicableUnknownPrimary
Feasibility Study of ExAblate Thalamotomy for Treatment of Chronic Trigeminal Neuropathic Pain
NCT02321566Phase 1Terminated
Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.
NCT03003715Not ApplicableCompletedPrimary
Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain
Showing all 3 trials
Research Network
Common Treatments
- Sham Tdcs Prior To Real Tdcs1
- Transcranial Direct Current Stimulation Tdcs1
- Pet Scans1
- Crossover Transcranial Exablate1
- Mri1
Active Sponsors
- InSightec1
- Johns Hopkins University1
- University of Michigan1
Top Investigators
University of Virginia
Johns Hopkins University
University of Michigan
Related Conditions
- Trigeminal Deafferentation Pain1
- Upper Extremity Pain Due To Deafferentation Of The Cervical Spine1
- Glossopharyngeal Neuralgia1
- Central Pain Syndromes1
- Trigeminal Neuralgia Burchiel Type I1